vs
Side-by-side financial comparison of KFORCE INC (KFRC) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $330.4M, roughly 1.5× KFORCE INC). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 2.4%, a 4.4% gap on every dollar of revenue. On growth, KFORCE INC posted the faster year-over-year revenue change (0.1% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -3.7%).
Kforce Inc. is a professional staffing and solutions firm headquartered in the United States. It provides skilled professional placements and specialized workforce solutions primarily across technology, finance & accounting, and healthcare segments, serving a wide range of mid-sized to large enterprise clients nationwide.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
KFRC vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $330.4M | $493.8M |
| Net Profit | $7.9M | $33.7M |
| Gross Margin | 27.3% | — |
| Operating Margin | 3.6% | 9.9% |
| Net Margin | 2.4% | 6.8% |
| Revenue YoY | 0.1% | -1.7% |
| Net Profit YoY | -2.7% | 10.5% |
| EPS (diluted) | $0.46 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $330.4M | — | ||
| Q4 25 | $332.0M | $493.8M | ||
| Q3 25 | $332.6M | $492.9M | ||
| Q2 25 | $334.3M | $468.8M | ||
| Q1 25 | $330.0M | $458.4M | ||
| Q4 24 | $343.8M | $502.4M | ||
| Q3 24 | $353.3M | $511.2M | ||
| Q2 24 | $356.3M | $504.3M |
| Q1 26 | $7.9M | — | ||
| Q4 25 | $5.2M | $33.7M | ||
| Q3 25 | $11.1M | $71.7M | ||
| Q2 25 | $10.4M | $39.3M | ||
| Q1 25 | $8.1M | $20.7M | ||
| Q4 24 | $11.1M | $30.5M | ||
| Q3 24 | $14.2M | $19.4M | ||
| Q2 24 | $14.2M | $-153.0M |
| Q1 26 | 27.3% | — | ||
| Q4 25 | 27.2% | — | ||
| Q3 25 | 27.7% | — | ||
| Q2 25 | 27.1% | — | ||
| Q1 25 | 26.7% | — | ||
| Q4 24 | 27.0% | — | ||
| Q3 24 | 27.9% | — | ||
| Q2 24 | 27.8% | — |
| Q1 26 | 3.6% | — | ||
| Q4 25 | 2.6% | 9.9% | ||
| Q3 25 | 4.5% | 13.8% | ||
| Q2 25 | 4.5% | 12.8% | ||
| Q1 25 | 3.5% | 7.0% | ||
| Q4 24 | 4.5% | 7.8% | ||
| Q3 24 | 5.3% | 6.6% | ||
| Q2 24 | 5.5% | -31.3% |
| Q1 26 | 2.4% | — | ||
| Q4 25 | 1.6% | 6.8% | ||
| Q3 25 | 3.3% | 14.5% | ||
| Q2 25 | 3.1% | 8.4% | ||
| Q1 25 | 2.5% | 4.5% | ||
| Q4 24 | 3.2% | 6.1% | ||
| Q3 24 | 4.0% | 3.8% | ||
| Q2 24 | 4.0% | -30.3% |
| Q1 26 | $0.46 | — | ||
| Q4 25 | $0.29 | $0.40 | ||
| Q3 25 | $0.63 | $0.84 | ||
| Q2 25 | $0.59 | $0.46 | ||
| Q1 25 | $0.45 | $0.24 | ||
| Q4 24 | $0.60 | $0.37 | ||
| Q3 24 | $0.75 | $0.23 | ||
| Q2 24 | $0.75 | $-1.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $117.4M | $865.9M |
| Total Assets | $384.8M | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.3M | — | ||
| Q4 25 | $2.1M | $375.2M | ||
| Q3 25 | $1.3M | $340.1M | ||
| Q2 25 | $2.5M | $224.7M | ||
| Q1 25 | $444.0K | $99.0M | ||
| Q4 24 | $349.0K | $229.9M | ||
| Q3 24 | $127.0K | $103.8M | ||
| Q2 24 | $110.0K | $19.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $117.4M | — | ||
| Q4 25 | $124.6M | $865.9M | ||
| Q3 25 | $132.1M | $890.7M | ||
| Q2 25 | $134.4M | $833.8M | ||
| Q1 25 | $138.0M | $789.2M | ||
| Q4 24 | $154.6M | $764.9M | ||
| Q3 24 | $167.4M | $732.5M | ||
| Q2 24 | $166.6M | $706.5M |
| Q1 26 | $384.8M | — | ||
| Q4 25 | $365.6M | $2.2B | ||
| Q3 25 | $374.2M | $2.2B | ||
| Q2 25 | $373.6M | $2.1B | ||
| Q1 25 | $368.2M | $2.0B | ||
| Q4 24 | $357.8M | $2.2B | ||
| Q3 24 | $369.9M | $2.1B | ||
| Q2 24 | $362.7M | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $114.1M |
| Free Cash FlowOCF − Capex | $-7.4M | — |
| FCF MarginFCF / Revenue | -2.2% | — |
| Capex IntensityCapex / Revenue | 1.0% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $43.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $19.7M | $114.1M | ||
| Q3 25 | $23.3M | $137.3M | ||
| Q2 25 | $18.4M | $137.2M | ||
| Q1 25 | $249.0K | $-117.5M | ||
| Q4 24 | $21.8M | $133.0M | ||
| Q3 24 | $31.0M | $91.8M | ||
| Q2 24 | $20.9M | $107.0M |
| Q1 26 | $-7.4M | — | ||
| Q4 25 | $16.7M | — | ||
| Q3 25 | $19.8M | — | ||
| Q2 25 | $14.2M | — | ||
| Q1 25 | $-3.9M | — | ||
| Q4 24 | $20.9M | — | ||
| Q3 24 | $27.5M | — | ||
| Q2 24 | $17.8M | — |
| Q1 26 | -2.2% | — | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 6.0% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | -1.2% | — | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 5.0% | — |
| Q1 26 | 1.0% | — | ||
| Q4 25 | 0.9% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 3.82× | 3.39× | ||
| Q3 25 | 2.11× | 1.91× | ||
| Q2 25 | 1.76× | 3.49× | ||
| Q1 25 | 0.03× | -5.66× | ||
| Q4 24 | 1.97× | 4.36× | ||
| Q3 24 | 2.18× | 4.72× | ||
| Q2 24 | 1.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KFRC
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
